Literature DB >> 18641637

Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation.

Arabella Meixner1, Rainer Zenz, Helia B Schonthaler, Lukas Kenner, Harald Scheuch, Josef M Penninger, Erwin F Wagner.   

Abstract

Mice that lack JunB in epidermal cells are born with normal skin; however, keratinocytes hyperproliferate in vitro and on TPA treatment in vivo. Loss of JunB expression in the epidermis of adult mice affects the skin, the proliferation of haematopoietic cells and bone formation. G-CSF is a direct transcriptional target of JunB and mutant epidermis releases large amounts of G-CSF that reach high systemic levels and cause skin ulcerations, myeloproliferative disease and low bone mass. The absence of G-CSF significantly improves hyperkeratosis and prevents the development of myeloproliferative disease, but does not affect bone loss. This study describes a mechanism by which the absence of JunB in epithelial cells causes multi-organ disease, suggesting that the epidermis can act as an endocrine-like organ.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641637     DOI: 10.1038/ncb1761

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  25 in total

1.  c-Jun promotes whereas JunB inhibits epidermal neoplasia.

Authors:  Jane Y Jin; Hengning Ke; Russell P Hall; Jennifer Y Zhang
Journal:  J Invest Dermatol       Date:  2011-02-03       Impact factor: 8.551

Review 2.  Psoriasis: what we have learned from mouse models.

Authors:  Erwin F Wagner; Helia B Schonthaler; Juan Guinea-Viniegra; Erwin Tschachler
Journal:  Nat Rev Rheumatol       Date:  2010-09-28       Impact factor: 20.543

3.  Genetic disruption of Fra-1 decreases susceptibility to endotoxin-induced acute lung injury and mortality in mice.

Authors:  Michelle Vaz; Narsa M Reddy; Subbiah Rajasekaran; Sekhar P Reddy
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

4.  JUNB/AP-1 controls IFN-γ during inflammatory liver disease.

Authors:  Martin K Thomsen; Latifa Bakiri; Sebastian C Hasenfuss; Rainer Hamacher; Lola Martinez; Erwin F Wagner
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

5.  Epidermal phospholipase Cδ1 regulates granulocyte counts and systemic interleukin-17 levels in mice.

Authors:  Kaori Kanemaru; Yoshikazu Nakamura; Kojiro Sato; Ryota Kojima; Saori Takahashi; Mami Yamaguchi; Manabu Ichinohe; Hiroshi Kiyonari; Go Shioi; Kenji Kabashima; Kyoko Nakahigashi; Masataka Asagiri; Colin Jamora; Hideki Yamaguchi; Kiyoko Fukami
Journal:  Nat Commun       Date:  2012-07-17       Impact factor: 14.919

6.  Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis.

Authors:  Helia B Schonthaler; Reto Huggenberger; Stefanie K Wculek; Michael Detmar; Erwin F Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-07       Impact factor: 11.205

7.  Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment.

Authors:  Vernon T Phan; Xiumin Wu; Jason H Cheng; Rebecca X Sheng; Alicia S Chung; Guanglei Zhuang; Christopher Tran; Qinghua Song; Marcin Kowanetz; Amy Sambrone; Martha Tan; Y Gloria Meng; Erica L Jackson; Franklin V Peale; Melissa R Junttila; Napoleone Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

8.  An NF-kappaB-dependent role for JunB in the induction of proinflammatory cytokines in LPS-activated bone marrow-derived dendritic cells.

Authors:  Tiphanie Gomard; Henri-Alexandre Michaud; Denis Tempé; Kevin Thiolon; Mireia Pelegrin; Marc Piechaczyk
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

9.  TNFalpha shedding and epidermal inflammation are controlled by Jun proteins.

Authors:  Juan Guinea-Viniegra; Rainer Zenz; Harald Scheuch; Denes Hnisz; Martin Holcmann; Latifa Bakiri; Helia B Schonthaler; Maria Sibilia; Erwin F Wagner
Journal:  Genes Dev       Date:  2009-11-15       Impact factor: 11.361

10.  CREB coactivators CRTC2 and CRTC3 modulate bone marrow hematopoiesis.

Authors:  Jeong-Ho Kim; Susan Hedrick; Wen-Wei Tsai; Ezra Wiater; John Le Lay; Klaus H Kaestner; Mathias Leblanc; Andrew Loar; Marc Montminy
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.